MAM
IART icon

Martingale Asset Management’s Integra LifeSciences IART Stock Holding History

Martingale Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,105
Closed -$1.44M – 871
2020
Q4 		$1.44M Sell
22,105
-13,474
-38% -$725K 0.02% 358
2020
Q3 		$1.68M Sell
35,579
-29,195
-45% -$1.39M 0.02% 470
2020
Q2 		$3.04M Buy
64,774
+18,693
+41% +$919K 0.04% 423
2020
Q1 		$2.06M Buy
46,081
+22,280
+94% +$1.17M 0.03% 483
2019
Q4 		$1.39M Buy
23,801
+3,597
+18% +$214K 0.01% 691
2019
Q3 		$1.22M Sell
20,204
-697
-3% -$41.5K 0.01% 724
2019
Q2 		$1.17M Hold
20,901
– – 0.01% 738
2019
Q1 		$1.17M Sell
20,901
-26,903
-56% -$1.37M 0.01% 750
2018
Q4 		$2.16M Sell
47,804
-40,705
-46% -$2.23M 0.03% 518
2018
Q3 		$5.83M Sell
88,509
-13,300
-13% -$827K 0.07% 286
2018
Q2 		$6.56M Sell
101,809
-1,703
-2% -$105K 0.08% 237
2018
Q1 		$5.73M Sell
103,512
-2,000
-2% -$105K 0.07% 253
2017
Q4 		$5.05M Sell
105,512
-18,900
-15% -$925K 0.07% 297
2017
Q3 		$6.28M Sell
124,412
-8,000
-6% -$411K 0.08% 248
2017
Q2 		$7.22M Sell
132,412
-1,000
-0.7% -$47.8K 0.1% 205
2017
Q1 		$5.62M Hold
133,412
– – 0.08% 264
2016
Q4 		$5.72M Buy
133,412
+16,398
+14% +$667K 0.08% 277
2016
Q3 		$4.83M Buy
117,014
+88,600
+312% +$3.71M 0.07% 281
2016
Q2 		$1.13M Sell
28,414
-2,400
-8% -$86.3K 0.02% 456
2016
Q1 		$1.04M Buy
30,814
+2
+0% +$62 0.02% 480
2015
Q4 		$1.04M Sell
30,812
-2
-0% -$63 0.02% 475
2015
Q3 		$918K Sell
30,814
-8,836
-22% -$276K 0.02% 505
2015
Q2 		$1.09M Sell
39,650
-734
-2% -$19.6K 0.03% 493
2015
Q1 		$1.02M Sell
40,384
-1,468
-4% -$34.7K 0.02% 519
2014
Q4 		$928K Buy
41,852
+1,226
+3% +$24.9K 0.03% 545
2014
Q3 		$825K Buy
+40,626
New +$809K 0.03% 557

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Martingale Asset Management's IART Position: Q1 2021 in Review

Martingale Asset Management sold out of Integra LifeSciences (IART) in Q1 2021, closing a stake of 22,105 shares — an estimated $1.44M sold.

Martingale Asset Management first reported a position in IART in Q3 2014 and held it in 26 quarters. The position peaked at $7.22M in Q2 2017. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

  • Martingale Asset Management reported no remaining Integra LifeSciences position as of Q1 2021 after selling out during the quarter.
  • Martingale Asset Management sold 22,105 Integra LifeSciences shares in Q1 2021, an estimated $1.44M.
  • Martingale Asset Management first reported a position in Integra LifeSciences in Q3 2014 and held it in 26 quarters.
  • Martingale Asset Management's Integra LifeSciences position peaked at $7.22M in Q2 2017.
  • 257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Martingale Asset Management's 13F filing for Q1 2021, filed 13 May 2021.